Current Topics in Healthcare 2022 September 2022

Comprehensive Update in Management of Diabetes Mellitus and Obesity Including Role of SGLT2 Inhibitors and Bariatric Surgery

5 hours | Wednesday, 09/21/2022
Check-in and Breakfast: 7:30AM
Educational Session: 8:00AM – 1:30PM

At the conclusion of this program, the participant will be able to:

1. Summarize recommendations from clinical practice guidelines regarding diabetes.
2. Discuss clinical evidence and place in therapy for oral diabetes and GLP-1 agonist agents.
3. Discuss the growing evidence and role of SGLT2 inhibitors and DPP-4 inhibitors within diabetes and non-diabetes patients.
4. Analyze role of bariatric surgery in management of morbid obesity and diabetes.
5. Describe complications and medication-related changed post-bariatric surgery.
6. Evaluate and develop medication regimens post-bariatric surgery through case studies.

Polypharmacy in the Elderly, Overview of Drug Interactions and Internal Medicine and Infectious Disease  Jeopardy

5 hours | Thursday, 09/22/2022
Check-in and Breakfast: 7:30AM
Educational Session: 8:00AM – 1:30PM

At the conclusion of this program, the participant will be able to:

Polypharmacy in the Elderly: Pitfalls, Pearls, and Plan:

1. Recognize factors leading to polypharmacy in the elderly.
2. Define inappropriate medications for elderly patients.
3. Describe tools to screen patients for polypharmacy.
4. Delineate best practices in polypharmacy through patient cases.

Overview of Drug Interactions

1. Identify common drug interaction mechanisms including cytochrome P450 enzymes.
2. Identify ten relevant clinical drug interactions for common medications.
3. Delineate assessment and management strategies for each drug interaction

Internal Medicine and Infectious Disease  Jeopardy

1. Identify evidenced-based guideline directed pharmacotherapy for select disease states.
2. Identify key therapeutic laboratory indices for selecting pharmacotherapy.

Opioids and Alternatives- Strategies to Optimize Success

5 hours | Friday, 09/23/2022
Check-in and Breakfast: 7:30AM
Educational Session: 8:00AM – 1:30PM

At the conclusion of this program, the participant will be able to:

1. Describe how the role for the use of opioids in acute, chronic, cancer/palliative care and end-of-life pain has changed in the past decade.
2. Describe the key features of the 2022 Proposed CMS Recommendations/Guidelines for prescribing opioids for outpatients.
3. Differentiate addiction, physical dependency, and tolerance.
4. State key principles managing patients with ongoing therapy that includes opioid analgesics, including stating “red flags” for opioid misuse, abuse and diversion, and how to anticipate and manage adverse drug events.
5. Identify the main characteristics of patients who would be identified as “high risk”, “moderate risk” and “low risk” for chronic opioid use.
6. State the definition of “hyperalgesia” and how to prevent/minimize this from negatively influencing the care of patients who are receiving opioids.
7. State three reasons why opioids may not be effective for some patients with chronic pain.
8. State key educational principles that should be applied to all  patients and caregivers regarding the safe use, proper storage and disposal of opioids.
9. Compare and contrast the pharmacological benefits and risks of the following non-opioid pharmacological options for managing pain:  a) cannabinoids; b) NSAIDS;  c) anti-convulsant; and, d) anti-depressants.

Dr. Gregory Holmquist PharmD-CPE